Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has announcements × Myelodysplastic Syndromes × entrectinib × Clear all

Sponsor

Conditions

Thyroid Cancer, Papillary 2 Sarcoma 2 Salivary Gland Neoplasms 2 Brain Neoplasms 2 Wilms Tumor 1 Solid Tumors 1 Sarcoma, Ewing 1 Recurrence 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neuroendocrine Tumors 1 Neuroblastoma 1 Nephroma, Mesoblastic 1 Neoplasm Metastasis 1 Melanoma 1 Medulloblastoma 1 Lymphoma, Large-Cell, Anaplastic 1 Locally Advanced Solid Tumors 1 Head and Neck Neoplasms 1 Glioma 1 Colorectal Neoplasms 1 Cholangiocarcinoma 1 Central Nervous System Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1

Interventions

Decitabine 3 decitabine and cedazuridine drug combination 2 cedazuridine 2 treosulfan 1 luspatercept 1 ivosidenib 1 imetelstat 1 glasdegib 1 enasidenib 1 GRN163L peptide 1 Daunorubicin 1 Cytarabine 1 Busulfan 1 Azacitidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡